When appetite drops, calories drop. When calories drop, two things shrink at once: fat mass and lean muscle mass. The ratio matters — and for people on GLP-1 medications, the ratio can tilt in the wrong direction if protein intake isn’t protected.
This isn’t fear-mongering. It’s geometry. And it’s probably the single most important nutritional reality of a GLP-1 journey that generic weight-loss advice completely misses.
The short version
Published research on GLP-1 therapy consistently shows meaningful weight loss over the first six to twelve months. It also consistently shows that a portion of that loss is lean mass, not just fat. The proportion varies by study, medication, and individual — but the signal is reliable enough that every responsible clinician will mention it.
Lean mass matters for reasons most people haven’t considered. It’s your metabolic engine — more muscle means more calories burned at rest. It’s your physical function — grip strength, stair-climbing, recovery from minor injuries. It’s also your insurance against regain — after medication ends, people with more lean mass retain their loss better on average than people with less.
Preserving lean mass during GLP-1 therapy comes down to two inputs: enough protein and enough resistance stimulus (whether that’s dedicated resistance training, bodyweight work, or physical activity that loads the muscles). This article focuses on protein.
What “enough” actually means
The general recommendation clinicians often cite for adults is around 0.8 grams of protein per kilogram of body weight per day. For people on GLP-1 medications, many clinicians suggest nudging this higher — toward 1-1.2 g/kg — specifically because the risk of muscle loss is elevated.
For a 75 kg person, that’s roughly 75-90 grams of protein per day. For context, that’s significantly more than most people eat by default — especially on days when appetite is low and eating feels like a chore.
The harder part: getting there on low-appetite days
The classic problem in GLP-1 life is protein arithmetic that works in theory but collapses in practice. You plan to eat a chicken breast at lunch. At lunchtime, the idea of a chicken breast is physically unappealing. You end up having half a protein bar and some fruit. You just logged 8 grams when you needed 30.
This happens constantly. It’s not a character flaw. It’s the medication doing exactly what it’s designed to do — reducing appetite signals. The work is in structuring the day so protein happens even when hunger doesn’t drive it.
Some approaches many users find helpful:
Front-load protein early. Morning appetite is often the strongest window. A Greek yogurt + chia + protein powder breakfast can deliver 25-30 grams before 9 AM. Many users find this more reliable than trying to catch up at dinner.
Smaller, more frequent protein touches. Instead of three big meals, consider five or six small ones — a cottage cheese at 10 AM, a handful of almonds at 3 PM, a boiled egg before bed. Totals add up.
Liquid protein on rougher days. On titration days or days with GI discomfort, a well-formulated protein shake can be easier to tolerate than a full meal. Many users keep one in the fridge as an insurance policy.
Choose protein density over bulk. Greek yogurt has more protein per bite than regular yogurt. Cottage cheese more than ricotta. Deli turkey more than lettuce. Small swaps compound.
The connection to Anchor
Anchor tracks protein daily — either through a quick photo estimation or manual entry — and correlates it against your energy, mood, and GI patterns. Within two weeks, most users can see the relationship between their protein intake and how they feel. For many users, the correlation is striking: days they hit their target, they feel noticeably better the next day.
This is the kind of pattern that’s invisible until someone puts the data together.
What this article is not
This isn’t a prescription, a diagnosis, or a clinical recommendation. Your protein targets are a conversation for your prescriber, registered dietitian, or other qualified healthcare professional — especially if you have kidney disease, other medical conditions, or specific medications that interact with protein metabolism. Anchor is educational scaffolding around that conversation, not a replacement for it.
What we can say, based on the research consistently and the patterns we see in our own users: during GLP-1 therapy, protein is worth thinking about more carefully than it probably was before.